β‘ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Vascular Pharmaceuticals Diabetes Research Initiatives just got measured.
4/10 means Vascular Pharmaceuticals Diabetes Research Initiatives is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Board of Directors Investors and Partners Vascular Pharmaceuticals is focused on rapidl Clinical Trials Patient Clinical Sites Science VPI-2690B Diabetic Nephropathy News and Researches Contact Us Vascular Pharmaceuticals is addressing the complications of diabetes Vascular Pharmaceuticals is pioneering a new approach to treat one of the most common complications of diabetes, diabetic nephropathy.
2
Structured Data
5
Content Structure
5
Entity Clarity
3
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Vascular Pharmaceuticals Diabetes Research Initiatives.
Scored by Engagemii on June 22, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/vascularpharma
Cite this score: Engagemii (2026). "AEO Score for Vascular Pharmaceuticals Diabetes Research Initiatives." Retrieved from https://engagemii.com/aeo/brands/vascularpharma
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform